Skip to main content

Advertisement

SpringerLink
Log in

Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Buggins AG, Milojkovic D, Arno MJ, Lea NC, Mufti GJ, Thomas NS et al. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 2001; 167: 6021–6030.

    Article  CAS  PubMed  Google Scholar 

  2. Milojkovic D, Devereux S, Westwood NB, Mufti GJ, Thomas NS, Buggins AG . Antiapoptotic microenvironment of acute myeloid leukemia. J Immunol 2004; 173: 6745–6752.

    Article  CAS  PubMed  Google Scholar 

  3. Lea NC, Orr SJ, Stoeber K, Williams GH, Lam EW, Ibrahim MA et al. Commitment point during G0 → G1 that controls entry into the cell cycle. Mol Cell Biol 2003; 23: 2351–2361.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A . The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood 2000; 96: 3932–3938.

    CAS  PubMed  Google Scholar 

  5. Conzen SD, Gottlob K, Kandel ES, Khanduri P, Wagner AJ, O'Leary M et al. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol Cell Biol 2000; 20: 6008–6018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ravandi F, Kantarjian HM, Talpaz M, O'Brien S, Faderl S, Giles FJ et al. Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance. Cancer 2001; 91: 1964–1972.

    Article  CAS  PubMed  Google Scholar 

  7. Ayanlar-Batuman O, Shevitz J, Traub UC, Murphy S, Sajewski D . Lymphocyte interleukin 2 production and responsiveness are altered in patients with primary myelodysplastic syndrome. Blood 1987; 70: 494–500.

    CAS  PubMed  Google Scholar 

  8. Chang WC, Fujimiya Y, Casteel N, Pattengale P . Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin-2 production by T-helper and natural killer cells. Int J Cancer 1989; 43: 591–597.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematological and Molecular Medicine, King's College London, Rayne Institute, London, UK

    D Milojkovic, A G S Buggins, S Devereux, N S B Thomas & G J Mufti

Authors
  1. D Milojkovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A G S Buggins
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Devereux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N S B Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G J Mufti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D Milojkovic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milojkovic, D., Buggins, A., Devereux, S. et al. Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently. Leukemia 19, 1699–1702 (2005). https://doi.org/10.1038/sj.leu.2403864

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403864

  • Springer Nature Limited

Search

Navigation